From: Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia
 | Imatinib | Nilotinib | Dasatinib | Bosutinib | Ponatinib |
---|---|---|---|---|---|
PAOD |  | ++ |  | +/− | ++ |
IHD/CVA | Â | + | Â | Â | + |
VTE | Â | Â | Â | Â | + |
Pulmonary hypertension | Â | Â | + | Â | Â |
Platelet dysfunction | Â | Â | + | Â | + |
Hypertension | Â | Â | Â | + | ++ |
Hyperglycemia | a | + | Â | Â | Â |
Dyslipidemia | a | + | Â | Â | Â |